CBX4 and cancer: In breast cancer, CBX4-mediated sumoylation of hTERT, the catalytic component of the human telomerase enzyme, causes the retention of the hTERT/ZEB1 complex at the CDH1 promoter, leading to its repression and then to EMT, promoting cancer cell migration and invasion [203].